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The in viieffcts ofxenoestrogens areofinterest inrelationto theirpotentialhealth risk and/or
beneficialefficts onhumans andanimals. However, the apparent inyim potencyofthe examined
responsecan beconfoundedbyashorthalf-ife, andthemetabolism ofestogensis verydependent
on the nature ofconversion and/or inactivation. To minimize such variables, we examined the
estrogenic potency of a range ofxenoestrogens in an acute in vivo assay-the stimulation of
increased uterinevascularpermeability in ovariectomized mice4hraftersubcutaneousadministra.
tion.Whileestradiol (E2)andestriol(F3; arelatilyweaknaturalestrogen)readilyinducedvascu-
lar responses [median effiv dose (ED50) 10-9 mol], much higher amounts ofxenoestrogens
were required. Bisphenol A was about 10,000-fold less potent than E4 and E, and octylphenol
and nonylphenol were about 100,000-fold less potent; dioctyl phthalat, beyl buty ptalate,
dibutylphtbalate, and trichlorinated biphenolproduced noeffect. Coumestrolwasthemostactive
phytoestrogen, with anED50 between 10-6 and 10-7 mol; genistein wa about 10-fold less potent
than coumestrol, and neither daidzein nor formononetin produced any marked efflect, even at
doses up to 1O5mol. All increases in vascular permeability could be blocked by the pure anti-
estrogenICI 182,780. Therewasnoevidence thatanyofthecompoundscouldact as ananiesro-
gen in his assayor that theycould exert ynegistc ef in.combion. These results indicate
that even short-term exposure to most ofthe xenobiotic estogens can induce typical estrogenic
efFecs in vivo, but theiresuogenic potency is veryweak evenwhen assessed in an acute response.
Keywori: environmentalestrogens,phytoestrogens,uteru,vasularpermeability,xenobiotic.
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There is considerable public and scientific
interest in the potential effects ofthe expo-
sure of humans and other animals to envi-
ronmental estrogens. These nonsteroidal
estrogenic compounds essentially fall into
two categories: they are derived from either
dietary sources or industrial sources. The
recent surge ofinterest in this area has large-
ly come from the use ofvery sensitive in
vitro assays, which have allowed the identifi-
cation ofweak estrogenic activity in many
industrially derived chemicals (1). This has
been coupled with natural and experimental
observations of estrogenic effects in aquatic
animals (e.g., fish) living under conditions
of continuous exposure to the compounds
(2). The possible health benefits ofdiets rich
in phytoestrogens has provided an addition-
al and alternative focus ofattention (3).
While the existence ofdietary and envi-
ronmental compounds with estrogenic
activity is clear, speculation linking them to
epidemiological data on fertility, reproduc-
tive abnormalities, and disease is severely
hampered by our very poor understanding
of the in vivo biological activity of these
compounds. In vitro assays have established
that all the compounds are relatively weak
estrogens, with both binding affinity to the
estrogen receptor and in vitro biological
activity usually <1/1,000 of estradiol (4).
However, it is difficult to extrapolate from
such in vitro data to the in vivo situation in
which the biological activity is dependent
on the complex in vivo pharmacokinetics
associated with uptake, distribution,
metabolism, and excretion.
There have been virtually no systemat-
ic, detailed studies of the nature and time
course of the estrogenic effects of these
chemicals in vivo in mammals. As a first
stage to assessing the in vivo estrogenic
activity, this study was undertaken to
establish the relative potency of the com-
pounds in an acute in vivo mammalian
assay. In vivo, the complex pattern ofestro-
genic action on the uterus can be dissociat-
ed into a group of early responses (e.g.,
increased vascular permeability, uterine
edema, uterine eosinophilia) and a group
of later responses (a host of biochemical
changes leading to cell division, differentia-
tion, and uterine growth) (5).
Estimates of estrogenic potency are
markedly affected depending on which of
these two groups of responses are used as
the baseline. Thus while estriol and estradiol
are relatively similar when assessed in terms
of the ability of single subcutaneous (sc)
injections to induce early uterine responses,
such single exposures to estriol are consider-
ably less effective than estradiol in produc-
ing sustained effects due to the rapid disso-
ciation ofestriol from its receptor (5).
The rationale behind this study was to
use one ofthe early specific estrogen-stim-
ulated responses as the basis for comparing
relative estrogenic potencies. This was
based on the assumption that estimates of
potency from early responses would mini-
mize complications arising from metabolism,
dearance, rapid dissociation from receptors,
etc. The early response chosen was the rapid
increase in uterine vascular permeability
[apparent within 15-30 min, with very large
responses (three- to fourfold increase) within
3-4 hr] of estrogen exposure (5,6). This
response has the advantage that it can be
readily quantified by monitoring the extrava-
sation of intravenously administered [1251]
labeled human serum albumin (7).
Methods
Animals. Female Swiss albino mice (A. Tuck
& Son Ltd., Battlesbridge, Essex, U.K.),
approximately 3 months ofage andweighing
25-35 g, were maintained under constant
conditions oflighting (lights on from 0600
hr to 1800 hr) and temperature (21 ± PC)
and fed on a pelleted diet (Economy Rodent
Maintenance, Essex, UK) ad libitum. All
experiments were performed on ovariec-
tomized animals. Ovariectomies were per-
formed under tribromoethanol anesthesia at
least 2 weeks before the start ofeach experi-
ment. All test compounds were administered
bysc injection in avolume of0.1 ml.
Chemicals. 17,-Estradiol (E2), genistein
(4',5,7-trihydroxyisoflavone), and daidzein
(4',7-dihydroxyisoflavone) were obtained
from Sigma Chemical Co. Ltd. (Dorset,
U.K.). Coumestrol (3,9-dihydroxy-6H-benzo-
furo-[3,2-c]-[l]benzopyran-6-one) and for-
mononetin (7-hydroxy4'-methoxyisoflavone)
were obtained from Acros Organics
(Springfield, NJ) and Extrasynthese (Genay,
France), respectively. 4-Nonylphenol, 4-tert-
octylphenol, bisphenol A [2,2-bis(4 hydrox-
yphenyl)propane, dioctyl phthalate, benzyl
butyl phthalate, and dibutyl phthalate were
obtained from Aldrich Chemical Co. Ltd.
(Gillingham, U.K.). Trichlorinated biphenol
(TCB; 3,4,3',4'-tetra-chlorobiphenyl) was a
gift from P. Darbre (University of Reading,
Reading, U.K.). Stocksolutions ofthechemi-
cals were normally dissolved in ethyl alcohol
or DMSO. The injection vehicle was either
arachis oil (phytoestrogens) or saline (others)
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containing 25% DMSO oralcohol. Thepure
antiestrogen ICI 182,780 (a gift from A.
Wakeling, Zeneca Pharmaceuticals,
Macclesfield, U.K.) was dissolved in alcohol
to give a stock solution of 10 mg/ml ethanol
andadministered in anarachisoilvehide.
Vascularpermeability changes in
response to test treatment. A quantitive
index ofthe permeability ofthe uterine vas-
culature 4 hr after sc injection of the test
compound was obtained from the leakage of
radiolabeled albumin from the circulation
(7,8). In brief, 3.5 hr after the injection of
the test substance, 50 pl 0.5 ,Ci [1251]-
labeled human serum albumin was injected
into the jugular vein of mice anesthetised
with tribromoethanol. Thirty minutes later,
a blood sample was drawn from the subor-
bital canthal sinus with a heparinized capil-
lary pipette and the animals were killed by
cervical dislocation. The blood sample was
centrifuged to provide a 100 pi plasma sam-
ple. The uteri and a sample ofthigh musde
were removed, briefly washed in saline, and
weighed. The radioactivity in the uterus,
plasma sample, and musde was determined.
Previous studies on the uterus (8,9,10) have
suggested that the blood volume of the
uterus isverymuch smallerthan thealbumin
space (after acirculation time of30 min) and
that the extravascular albumin space is the
major determinant ofthe total tissue albu-
min space. The tissue-specific extravascular
albumin volume (EAV) was expressed as a
ratio ofthe [125I] counts per minute per mil-
ligram oftissue to [1251] counts per minute
permicroliter ofplasmaand used as an index
oftissuevascularpermeability (7).
Analyses of results. Results were
expressed as mean ± standard error (SE) and
analyzed using analysis of variance
(ANOVA).
Results
Experiment 1-Dose-response effects of
xenobiotic estrogens on uterine vascular
permeability. Ovariectomized mice were
injectedwith oneofthefollowinginavolume
of 0.1 ml saline: control vehicle, E2 (10-12
-10-9 mol), or various doses ofE3, coume-
strol, genistein, diadzein, formonetin,
nonylphenol, octylphenol, bisphenol A,
dioctyl phthalate, dibutyl phthalate, and
benzyl butyl phthalate; uterine vascular per-
meability was determined 4 hr later. The
results are shown in Figures 1 and 2. E2
induced a marked increase in uterine vascu-
lar permeability at injected doses down to
1010 mol. Thehighest doses ofE2 produced
a fourfold increase in extravascular albumin
volumes (>22 jl/mg compared to <4 pl/mg
for controls), with about 10-9-10~1U mol
being required to produce half-maximal
(EAV= 13 plimg) stimulation. E3 was also
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Figure 1. The dose-response effects of 1713-estradi-
ol, estriol, and the environmental estrogens bisphe-
nol A, octylphenol, and nonylphenol on uterine vas-
cular permeability 4 hr after subcutaneous adminis-
tration in ovariectomized mice. Saline controls were
included for each experimental data point Vascular
permeability was determined by the extravascular
accumulation of [12511-albumin and was expressed
as extravascular albumin volume (EAV; see
Methods). The data are expressed as mean ± stan-
dard error (n = 6-12). Where no error bars are
shown, the errors were smaller than the symbol.
Statistical significance was determined by compari-
sonwiththe controls.
*p<0.05;**p".01; lp<0.001.
very effective in stimulating vascular perme-
ability, with a median effective dose (ED50)
<10-9 mol. All the other industrial com-
pounds were required at considerably higher
doses before any increase in uterine vascular
permeability was observed (Fig. 1), and some
showed no effect at all. Compared to E21
bisphenol A was about 10,000 times less
effective in inducing the uterine vascular
response (ED50-10-5 mol), and octylphenol
and nonylphenol were about 100,000 times
less effective (ED50 _104 mol). The three
phthalates, dioctyl phthalate, benzyl butyl
phthalate, and dibutyl phthalate (104 mol),
and trichlorinated biphenol (10-8 mol) pro-
duced no significant effecton uterine vascular
permeability.
Coumestrol was the most potent of the
phytoestrogens (ED50 between 106 and 10-7
mol), butstill required 100-1,000-fold high-
er doses ofthe compound than E2 (Fig. 2).
The amount ofgenistein required to induce
the vascular response was about 10-fold
higher again, while neither daidzein nor for-
mononetin produced any marked effects,
evenwhengiven atdoses up to 10-5 mol.
Experiment 2-The ability ofthe
antiestrogen ICI 182,780 to inhibit
estrogen-inducedincreases in uterine vas-
cularpermeability. Ovariectomized mice
were subjected to daily sc injections of 100
pg ICI 182,780 for 4 days. One hour after
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Figure2 The dose-response effects of17f3-estradi-
ol, estriol, and the phytoestrogens coumestrol,
genistein, and daidzein on uterine vascular perme-
ability 4 hr after subcutaneous administration in
ovariectomized mice. Saline controls were included
for each experimental data point. Vascular perme-
ability was determined by the extravascular accu-
mulation of [12511-albumin and was expressed as
extravascular albumin volume (EAV; see Methods).
The data are expressed as mean ± standard error
(n = 6-12). Where no error bars are shown, the
errors were smallerthanthe symbol. Statistical sig-
nificance was determined by comparison with the
controls.
*p<0.05;**p<O.Ol;p<O".OOl.
the last injection, the mice were given a
single sc injection of one ofthe following:
E2 (at doses of 10-11, 10-10, and 10-9 mol),
E3 (10-9 mol), coumestrol (10-7 mol),
genistein (10-6 mol), nonylphenol (10-4
mol), octylphenol (10-4 mol), and bisphe-
nol A (10-5 mol); vascular permeability was
determined 4 hr later. Pretreatment with
the antiestrogen ICI 182,780 suppressed
the increase in vascular permeability
induced by the estriol (10-9 mol) and the
lower dose of estradiol (<10IO mol). The
antiestrogen suppressed the vascular
responses to all the other substances tested
(Table 1). There were no significant effects
of the antiestrogen on the vascular perme-
ability in the control tissue.
Expem ent3-The ef)cst of w levels
ofenvironmental estrogens on estradiol-
stimuledinceasesin vaulrpermbilj
ity. The possibility that low doses ofxenobi-
oticestrogens (i.e., belowthelevel required to
induce an estrogenic response) might act as
antiestrogens was investigated by examining
the effect of a nonstimulatory dose ofthe
compounds in combinationwith astimulato-
ry dose ofE2. Ovariectomized mice were
injected scwith E2 (10-10 mol) togetherwith
either coumestrol (10-8 mol), daidzein (10-5
mol), formononetin (10-5 mol), nonylphenol
(106 mol), octylphenol (106 mol), bisphenol
A (10-7 mol), dioctyl phthalate (10- mol),
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Table 1. The ability ofthe antiestrogen ICI 182,780 to inhibit estrogen-induced increases in uterine vascular
permeability
Compound
administered
(mol)
Control
ICI 182,780
173-Estradiol 10-12
17p-Estradiol 10-12+ ICI
17,B-Estradiol 10-10
17p-Estradiol 10-10+ ICI
17fi-Estradiol 10-9
17j3-Estradiol 10-9+ ICI
Coumestrol 10-7
Coumestrol 10-7 + ICI
Genistein 10-6
Genistein 10-6 + ICI
Estriol 10-9
Estriol 10-9 + ICI
Nonylphenol 10-4
Nonylphenol 10-4 + ICI
Octylphenol 10-4
Octylphenol 10-4 + ICI
Bisphenol A 10-5
Bisphenol A 10-5 + ICI
Number
of mice
12
6
6
6
6
6
6
6
6
6
8
6
6
6
6
6
6
6
6
6
Uterine
weight
(mg)
13.00 ± 1.25
8.47 ± 0.01
16.82 ± 0.02
10.05 ± 0.01
18.72 ± 0.01
13.23 ± 1.32
17.38 ± 1.83
16.12 ± 0.01
19.58 ± 1.85
15.10 ± 0.01
19.56 ± 1.11
13.16 ± 0.09
26.5 + 0.02
16.32 ± 0.02
18.80 ± 0.01
15.08 ± 0.03
12.60 ± 1.52
13.07 ± 0.01
16.50 ± 1.20
8.15 ± 0.03
Uterine vascular
permeability
ratio (%)
4.26 + 0.51
4.20 ± 0.27
3.53 ± 0.39
3.40 ± 0.12
17.63 ± 2.04
7.83 ± 1.73*
25.79 ± 1.90
22.19 ± 2.50
28.40 ± 2.98
4.31 ± 0.36*
25.43 ± 1.92
5.92 ± 0.54*
18.27 ± 2.70
12.8 ± 1.46*
16.74 ± 3.06
4.53 ± 1.17*
18.45 ± 3.49
5.7 ± 0.10*
15.18 ± 2.40
3.67 ± 0.48*
Muscle vascular
permeability
ratio (%)
0.64 ± 0.08
0.47 ± 0.04
0.5 ± 0.04
0.44 ± 0.06
0.47 ± 0.05
0.61 ± 0.03
0.42 ± 0.02
0.46 ± 0.05
0.50 ± 0.01
0.57 ± 0.04
0.60 ± 0.08
0.55 ± 0.04
0.54 ± 0.04
0.51 ± 0.04
0.47 ± 0.05
0.65 ± 0.11
0.53 ± 0.06
0.44 ± 0.04
0.42 ± 0.02
0.45 ± 0.02
Ovariectomized mice were subjected to daily subcutaneous (sc) injections of 100 pg ICI 182,780 for 4 days. One hour after
the fourth injection, the test compound was administered sc. Saline controls were included for each experimental data
point. Vascular permeability was determined by the extravascular accumulation of[12511-albumin and was expressed as a
ratio (mean ± standard error) ofthe 112511 counts per minute per milligram oftissue to [12511 counts per minute per microliter
of plasma. Thigh muscle was the control tissue.
*Significantly lowerthan the test compound alone Ip<0.OO
dibutyl phthalate (10-4 mol), or benzyl butyl
phthalate (10-4 mol), and uterine vascular
permeability was determined. There was no
evidence that any ofthe environmental estro-
gens (at the doses given) produced anysignif-
icant (p<0.05) inhibitoryeffect on the estradi-
ol-stimulated increase in vascular permeabili-
ty. The index ofvascular permeability was
12.9 ± 2.5 .l/mg (mean ± SE) for E2 (10o
mol) alone, while the combination ofE2 with
the other estrogenic compounds gave values
of 10.3 ± 1.5 for nonylphenol and octylphe-
nol (each at a dose of 10-6 mol), 14 ± 2.8 for
bisphenol A (10-8 mol), and 11.4 ± 1.6 for
dioctyl phthalate, 12.1 ± 1.8 for dibutyl
phthalate, and 14.9 ± 1.1 (pd/mg for benzyl
butyl phthalate (all atdoses of10- mol).
Experiment 4-The effects ofcombina-
ionsofavarietyofenvironmentlestrogens
on uterine vascularpermeability. The effect
oflow doses ofdifferent compounds given in
combination was examined to determine
whether there was any evidence ofsynergistic
interactions in the induction of increases in
uterine vascular permeability. Ovariectomized
mice were injected sc with one ofthe follow-
ing combinations: 1) nonylphenol (10-6 mol),
octylphenol (10-6 mol), andbisphenol A (10-7
mol); and 2) dibutyl phalate (10-4 mol),
dioctyl phalate (10-4 mol), and benzyl butyl
phalate (104 mol). There was no evidence of
any significant (p>0.05) postive or negative
synergy or negative effects between the com-
pounds (at the doses used) in any of the
combinations tested in terms ofinducing an
increase in vascular permeability. In control
uteri, the index ofvascular permeability was
4.2 ± 0.51 pil/mg (mean ± SE); the combina-
tion ofnonylphenol with octylphenol (both
at 10-6mol) and bisphenol A (10-7 mol) pro-
duced an index of 2.91 ± 0.27 Pl/mg; for
dibutyl phthalate with benzyl butyl phthalate
and dioctyl phthalate (all at 10-3 mol), the
index of vascular permeability was 2.79 ±
0.54 pl/mg.
Discussion
The availability of very sensitive in vitro
bioassays for estrogens has led to the identifi-
cation of estrogenic activity in many indus-
trial (11,12) and plant-derived compounds
(13). However, even in vitroassays, the estro-
genic activity of these compounds is usually
less than 1/1,000-1/100,000 that of E2
(1,4,11-13). Our data is in general agree-
ment with published data on the in vitro
potency ofthe xenobiotic estrogens, empha-
sizing that these compounds can only exert
significant estrogenic activity when present
in very large quantities. Bisphenol A appears
to be one of the more potent xenobiotic
estrogens (14,15); a recent in vivo study in
rats examining prolactin secretion (14) sug-
gested that bisphenol A was only 100-500-
fold less active than E2, while bisphenol A
potency in vitro was 1,000-5,000-fold less
than E2. In the present study, bisphenol A
was about 10,000-fold less potent than E2.
These observations, coupled with the present
observations, suggest that in vitropotencies of
xenobiotic estrogens may not be an accurate
guide to in vivopotencies, and estimates ofin
vivopotencywill depend on the assayused.
The in vivoestrogenic potencyofxenobi-
otic estrogens has received rather superficial
attention, with results largely based on uter-
ine growth after daily sc injections (16) or
after administration by gavage (17).
However, the relative potency of estrogenic
compounds depends on a number offactors,
including the route of administration and
the nature of the response monitored. The
particular problem of using uterine growth
respotnses to assess estrogenic potency is well
illustrated bycomparing the effects ofE2and
E3. while single sc injections ofeitherofthese
hormones areveryeffective in inducing rapid
uterine responses (that occur within a few
hours of administration), E3 is unable to
mimic E2 in terms of the uterine growth
response measured at 24 hr after injection
(5). Such differences in estrogenic responses
led to E3 being described as a weak estrogen
(18). However, the apparent low potency of
single injections of E3 to induce uterine
growth hides the biological reality of the
estrogenic response. E3 is fully effective in
producing the complete ranige of estrogenic
responses when it is given as rapidly repeated
injections (5) or as slow-release implants
(195. These apparent differences between E3
and E2 in terms of their potency to induce
acute and sustained responses highlight the
difficultyofinterpreting assessments ofestro-
genic potency by just single in vivo assay
methods. In contrast to the long-term nature
ofuterine growth assays, the increase in uter-
ine vascular permeability is an acute, rapid,
easily monitored response of the uterus to
estrogenic stimulation (7). The estrogen
receptor-mediated nature of this response
was confirmed in the present study by the
ability ofthe pure antiestrogen ICI 182,780
to block the responses induced by E2' E3,
and other compounds. The present stuJy
provides a direct indication of the acute in
vivo potencies of a variety of dietary and
industrial estrogenic compounds on an
important target site for estrogens in female
mammals. The results indicate that, even
when measured in terms of their ability to
induce acute responses, the activity ofsuch
compounds is very low in comparison with
established estrogens like E2 andE3.
The relative potency ofany of the envi-
ronmental estrogens compared to E3 and E2
in this acute assay is particularly interesting.
While E3 is a relatively weak estrogen in
terms ofany long-term growth responses to
acute exposures, it is almost as effective as
E2 in inducing rapid estrogenic effects in
the uterus. However, even in this rapid in
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vivo assay that allows the estrogenic activity
ofthe relatively weak E3 to be exposed, the
potency of all the weak environmental
estrogens was considerably lower. This
would tend to emphasize that prolonged in
vivo estrogenic responses to such com-
pounds are unlikely to occur unless the
exposures are both considerable and
extended; this is currently under investiga-
tion. However, the possibility that acute
exposures to these compounds may induce
significant, although short-term, estrogenic
responses should not be underemphasized.
Rapid responses to estrogens are an impor-
tant feature of a number of reproductive
processes, such as control of the cell cycle
(5) and the sensitivity of the uterus to an
implanting blastocyst (20); exogenous
estrogenic agents may be able to either
mimic endogenous estrogens and/or pro-
vide a disturbance to the sequence of
endogenous estrogenic stimulation essential
for the normal pattern ofuterine responses.
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